Skip to main content

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  221.27
+0.00 (0.00%)
AAPL  271.84
+0.00 (0.00%)
AMD  198.11
+0.00 (0.00%)
BAC  54.55
+0.00 (0.00%)
GOOG  298.05
+0.00 (0.00%)
META  649.50
+0.00 (0.00%)
MSFT  476.12
+0.00 (0.00%)
NVDA  170.94
+0.00 (0.00%)
ORCL  178.46
+0.00 (0.00%)
TSLA  467.26
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.